Prevalence and Clinical Correlates of Metabolic Syndrome in Psoriasis Patients at a Tertiary Care Hospital in Pakistan
DOI:
https://doi.org/10.52206/jsmc.2025.15.3.1099Abstract
Background: Psoriasis is a chronic, immune-mediated inflammatory skin disease affecting approximately 2–3% of the global population. Metabolic syndrome (MetS) is a cluster of metabolic abnormalities—central obesity, insulin resistance, dyslipidemia, and hypertension—that heightens the risk of cardiovascular disease and type 2 diabetes.
Objective: To determine the frequency of metabolic syndrome in psoriasis patients presenting to the dermatology unit at a tertiary care hospital in, Pakistan.
Methodology: This cross-sectional study was conducted from June 27, 2021, to December 26, 2021, in the dermatology unit. A total of 143 clinically diagnosed psoriasis patients aged 20–60 years of both sexes were enrolled. Key components of metabolic syndrome—including blood pressure, waist circumference, triglyceride levels, high-density lipoprotein (HDL) cholesterol, and random blood glucose—were measured in accordance with NCEP ATP III criteria.
Results: Among the 143 patients, the mean age was 35.3 ± 9.2 years; 44% were male and 56% were female. The mean Body Mass Index (BMI) was 26.3 ± 3.4 kg/m². The prevalence of metabolic syndrome was 45.4%. Statistically significant associations were found between metabolic syndrome and smoking status, diabetes mellitus, elevated blood glucose levels, and increased BMI (p < 0.05).
Conclusion: The frequency of metabolic syndrome among psoriasis patients in this cohort was notably high. These findings underscore the need for early screening and comprehensive management of metabolic risk factors in psoriasis patients, particularly in the local Pakistani population.
Keywords: Body Mass Index, Cardiovascular Risk, Dermatology, Metabolic Syndrome, Psoriasis.
References
Yamanaka K, Yamamoto O, Honda T. Pathophysiology of psoriasis: A review. The Journal of dermatology. 2021 Jun;48(6):722-31. https://doi.org/10.1111/1346-8138.15913
Wu JJ, Kavanaugh A, Lebwohl MG, Gniadecki R, Merola JF. Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis. Journal of the European Academy of Dermatology and Venereology. 2022 Jun;36(6):797-806. https://doi.org/10.1111/jdv.18044
Yang W, Cai X, Hu J, Wen W, Mulalibieke H, Yao X, et al. The metabolic score for insulin resistance (METS-IR) predicts cardiovascular disease and its subtypes in patients with hypertension and obstructive sleep apnea. Clinical epidemiology. 2023 Dec 31:177-89. https://doi.org/10.2147/CLEP.S395938
Nikolopoulou A, Kadoglou NP. Obesity and metabolic syndrome as related to cardiovascular disease. Expert review of cardiovascular therapy. 2012 Jul 1;10(7):933-9. https://doi.org/10.1586/erc.12.74
Raza MH, Iftikhar N, Mashhood AA, Hamid MA, Rehman F, Tariq S. Frequency of metabolic syndrome in patients with psoriasis. Journal of Ayub Medical College Abbottabad. 2021 Jun 30;33(3):484-7. http://www.jamc.ayubmed.edu.pk/index.php/jamc/article/view/9219/3149
Souza CS, de CASTRO CC, Carneiro FR, Pinto JM, Fabricio LH, Azulay?Abulafia L et al. Metabolic syndrome and psoriatic arthritis among patients with psoriasis vulgaris: Quality of life and prevalence. The Journal of dermatology. 2019 Jan;46(1):3-10. https://doi.org/10.1111/1346-8138.14706
Yamanaka K, Yamamoto O, Honda T. Pathophysiology of psoriasis: A review. The Journal of dermatology. 2021 Jun;48(6):722-31. https://doi.org/10.1111/1346-8138.15913
Lee D, Koo T, Park J, Shin HT. Comparison of risk allele frequencies of Psoriasis-Associated single-nucleotide polymorphisms in different Population groups. Annals of Dermatology. 2023 Jan 20;35(1):32. http://doi.org/10.5021/ad.22.110
Wu JJ, Kavanaugh A, Lebwohl MG, Gniadecki R, Merola JF. Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis. Journal of the European Academy of Dermatology and Venereology. 2022 Jun; 36(6):797-806. https://doi.org/10.1111/jdv.18044
Al-Mendalawi MD. Metabolic Syndrome in Patients with Psoriasis: A Hospital-Based Case–Control Study. Clinical Dermatology Review. 2020 Jan 1;4(1):64. http://doi.org/10.4103/CDR.CDR_31_18
Br?ni?teanu DE, Ciobanu RP, Branisteanu DC, Colac-Bo?oc C, Hu?anu AE, Munteanu CA et al. Prevalence of Psychiatric and Addictive Disorders in Patients with Psoriasis: A Cross-Sectional Study. Diagnostics. 2025 May 14;15(10):1231. https://doi.org/10.3390/diagnostics15101231
Nwankwo M, Okamkpa CJ, Danborno B. Comparison of diagnostic criteria and prevalence of metabolic syndrome using WHO, NCEP-ATP III, IDF and harmonized criteria: A case study from urban southeast Nigeria. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2022 Dec 1;16(12): 102665. https://doi.org/10.1016/j.dsx.2022.102665
Kaur G, Kaur S, Rana R, Kumar B, Melkani I, Kumar S et al. Pathogenesis, molecular mechanism and treatment approaches of psoriasis: An update. InAIP Conference Proceedings. 2024 Feb 20 (Vol. 2986, No. 1). https://doi.org/10.1063/5.0192550
Bakirtzi K, Sotiriou E, Papadimitriou I, Sideris N, Vakirlis E, Lallas A et al. Elderly patients with psoriasis: long-term efficacy and safety of modern treatments. Journal of Dermatological Treatment. 2022 Apr 3;33(3):1339-42. https://doi.org/10.1080/09546634.2020.1809623
Hao Y, Zhu YJ, Zou S, Zhou P, Hu YW, Zhao QX, et al. Metabolic syndrome and psoriasis: mechanisms and future directions. Frontiers in immunology. 2021 Jul 23;12:71106. https://doi.org/10.3389/fimmu.2021.711060
Mustata ML, Neagoe CD, Ionescu M, Predoi MC, Mitran AM, Ianosi SL. Clinical Implications of Metabolic Syndrome in Psoriasis Management. Diagnostics. 2024 Aug 14;14(16):1774. https://doi.org/10.3390/diagnostics14161774
Pannu S, Rosmarin D. Psoriasis in patients with metabolic syndrome or type 2 diabetes mellitus: treatment challenges. American Journal of Clinical Dermatology. 2021 May;22:293-300. https://doi.org/10.1007/s40257-021-00590-y
Ad??en E, Uzun S, Erduran F, Gürer MA. Prevalence of smoking, alcohol consumption and metabolic syndrome in patients with psoriasis. Anais brasileiros de dermatologia. 2018;93(2):205-11. https://doi.org/10.1590/abd1806-4841.20186168
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 The authors retain the copyrights. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website), as it can lead to productive exchanges, as well as greater citation of published work.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
